José Carlos
Martínez Salgado
Hospital Universitario de Salamanca
Salamanca, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario de Salamanca (43)
2021
-
Albuminuria pre-emptively identifies cardiac patients at risk of contrast-induced nephropathy
Journal of Clinical Medicine, Vol. 10, Núm. 21
2020
-
Urinary transferrin pre-emptively identifies the risk of renal damage posed by subclinical tubular alterations
Biomedicine and Pharmacotherapy, Vol. 121
2018
-
Influence of angiogenic mediators and bone remodelling in paget´s disease of bone
International Journal of Medical Sciences, Vol. 15, Núm. 11, pp. 1210-1216
-
Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patients
Nefrologia, Vol. 38, Núm. 5, pp. 520-527
2017
-
Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors
Scientific Reports, Vol. 7
2016
-
Absence of K-Ras Reduces Proliferation and Migration But Increases Extracellular Matrix Synthesis in Fibroblasts
Journal of Cellular Physiology, Vol. 231, Núm. 10, pp. 2224-2235
-
Association between different risk factors and vascular accelerated ageing (EVA study): Study protocol for a cross-sectional, descriptive observational study
BMJ Open, Vol. 6, Núm. 6
-
Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease
Kidney International, Vol. 90, Núm. 1, pp. 77-89
-
Identification of bone morphogenetic protein 9 (BMP9) as a novel profibrotic factor in vitro
Cellular Signalling, Vol. 28, Núm. 9, pp. 1252-1261
-
Mechanisms of triple whammy acute kidney injury
Pharmacology and Therapeutics, Vol. 167, pp. 132-145
-
Serum Superoxide Dismutase Is Associated with Vascular Structure and Function in Hypertensive and Diabetic Patients
Oxidative Medicine and Cellular Longevity, Vol. 2016
2015
-
Increased Klk9 urinary excretion is associated to hypertension-induced cardiovascular damage and renal alterations
Medicine (United States), Vol. 94, Núm. 41
-
Plasma cardiotrophin-1 as a marker of hypertension and diabetes-induced target organ damage and cardiovascular risk
Medicine (United States), Vol. 94, Núm. 30
-
TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations?
Pharmacology and Therapeutics, Vol. 156, pp. 44-58
2014
-
ALK1 heterozygosity increases extracellular matrix protein expression, proliferation and migration in fibroblasts
Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1843, Núm. 6, pp. 1111-1122
-
Heterozygous disruption of activin receptor-like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy
Kidney International, Vol. 85, Núm. 2, pp. 319-332
-
Hypertension and hyperglycemia synergize to cause incipient renal tubular alterations resulting in increased NGAL urinary excretion in rats
PLoS ONE, Vol. 9, Núm. 8
2013
-
Concerted action of ANP and dopamine D1-receptor to regulate sodium homeostasis in nephrotic syndrome
BioMed Research International, Vol. 2013
-
Influence of body mass index on the association of weight changes with mortality in hemodialysis patients
Clinical Journal of the American Society of Nephrology, Vol. 8, Núm. 10, pp. 1725-1733
-
TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1832, Núm. 10, pp. 1744-1755